Rock Point Advisors »

iShares Dow Jones US Pharm Indx shares owned by Rock Point Advisors

Quarter-by-quarter ownership of iShares Dow Jones US Pharm Indx (IHE) shares owned by Rock Point Advisors from 13F filings

Historical chart of Rock Point Advisors investment in iShares Dow Jones US Pharm Indx

Tip: Access up to 7 years of quarterly data

All positions including iShares Dow Jones US Pharm Indx held by Rock Point Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in iShares Dow Jones US Pharm Indx by Rock Point Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $225k 1.2k 185.40

More positions owned by Rock Point Advisors

Citigroup Com New (C)
Kennedy-Wilson Holdings (KW)
Jefferies Finl Group (JEF)
Sp Plus (SP)
Evolent Health Cl A (EVH)
Broadcom (AVGO)
TJX Companies (TJX)
Triumph (TGI)
Apple (AAPL)
Aptiv SHS (APTV)
Sony Group Sponsored Adr (SONY)
Accenture SHS Class A (ACN)
American International Group Com New (AIG)
Ameresco Cl A (AMRC)
Paramount Global Class B Com (PARA)

View all positions for Rock Point Advisors

Top funds holding iShares Dow Jones US Pharm Indx

Fisher Investments
Accurate Wealth Management
Brown Advisory Holdings Incorporated
Bank of America Corporation
Raymond James & Associates
Royal Bank of Canada
Commonwealth Equity Services
Citadel Advisors
Wells Fargo & Company
Massachusetts Wealth Management
UBS Group
Raymond James Financial Services Advisors
Goldman Sachs Group
Janney Montgomery Scott
GSA Capital Partners

View all funds holding iShares Dow Jones US Pharm Indx